TGFB1 and colorectal carcinoma: Hence, through adequately exploring the association of TGF-β signaling-related TME alterations and CRC progression, it is not surprising that C1 and C2 subtypes exhibited significant differences in survival outcomes and the status of immune checkpoint genes.